
What smart money is saying about Globus Medical
1 fund in our archive has pitched Globus Medical — most recently Antipodes Global Value Active ETF in September 2025.
Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.
Get an email when a fund writes about it
Fund coverage · 1 thesis
- Antipodes Global Value Active ETFSeptember 2025
Globus Medical is a leading medical devices manufacturer in spinal orthopedics, poised for growth through innovation and strategic expansion, supported by favorable market trends and a strong financial position.
Read the full thesis
Read every full thesis on Globus Medical
Unlock all 1 thesis — the full reasoning behind what funds are buying, plus unlimited access to the entire archive.
View plans→